Crystal structure of chimeric PDE5/PDE6 catalytic domain complexed with 3-isobutyl-1-methylxanthine…
HeteromerP18545 ; P51160 ; 537-859
100 1×ZN; 1×MG; 3×IBM; Crystal structure of GAFb from the human phosphodiesterase 5 homo-4-mer 346-509
100.0 crystal structure of unliganded PDE5A GAF domain homo-2-mer 98-518
99.74 Crystal structure of PDE5A GAF domain (89-518) homo-2-mer 101-518
99.73 Crystal structure of Human Phosphodiesterase 5 complexed with tadalafil(Cialis) homo-2-mer 537-860
100.0 2×ZN; 2×MG; 2×CIA; Catalytic Domain Of Human Phosphodiesterase 5A monomer 534-862
100.0 1×ZN; 1×PO4; 1×CIT; Crystal structure of PDE5A1 in complex with icarisid II monomer 535-860
100 1×ZN; 1×MG; 1×7CA; Crystal structure of the catalytic domain of unliganded PDE5 monomer 535-860
100.0 1×ZN; 1×MG; Crystal structure of PDE5 in complex with inhibitor 5R monomer 535-860
100.0 1×SO4; 1×24E; 1×ZN; 1×MG; Crystal structure of the PDE5A catalytic domain in complex with a novel inhibitor monomer 535-860
100.0 1×ZN; 1×MG; 1×WAN; Crystal structure of PDE5A1-IBMX monomer 535-860
99.68 1×ZN; 1×MG; 1×IBM; Crystal Structure of PDE5A1 catalytic domain in complex with Vardenafil monomer 535-860
100.0 1×VDN; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 535-860
100.0 1×5EO; 1×ZN; 1×MG; Crystal structure of PDE5 in complex with sildenafil monomer 535-860
100 1×ZN; 1×MG; 1×VIA; Crystal structure of PDE5 in complex with inhibitor LW1634 monomer 535-860
100.0 1×ZN; 1×MG; 1×SO4; 1×9M0; Crystal structure of PDE5 in complex with inhibitor LW1805 monomer 535-860
100.0 1×SO4; 1×ZN; 1×MG; 1×9T9; Catalytic Domain Of Human Phosphodiesterase 5A in Complex with Sildenafil monomer 534-858
94.77 1×ZN; 1×MG; 1×VIA; 1×GOL; Catalytic Domain Of Human Phosphodiesterase 5A In Complex With Tadalafil monomer 534-858
94.77 1×ZN; 1×MG; 1×CIA; Catalytic Domain Of Human Phosphodiesterase 5A In Complex With Vardenafil monomer 534-858
94.77 1×ZN; 1×MG; 1×VDN; Crystal structure of PDE5A in complex with CVT-313 monomer 536-860
100.0 1×MG; 1×ZN; 1×AJR; Catalytic Domain Of Human Phosphodiesterase 5A in Complex with GMP monomer 534-858
94.77 1×ZN; 1×MG; 1×5GP; Crystal structure of PDE5A in complex with a novel inhibitor monomer 536-860
100.0 1×MG; 1×ZN; 1×B0C; crystal structure of PDE5 in complex with a non-competitive inhibitor monomer 535-859
100.0 1×FZA; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 536-860
100.0 1×5CO; 1×ZN; 5×MG; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 536-860
100.0 1×5FO; 1×ZN; 3×MG; Human PDE5 catalytic core in complex with avanafil monomer 536-859
100 1×E6L; 1×ZN; 1×MG; 1×SO4; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 535-858
100.0 1×5BA; 1×ZN; 1×MG; 2×PEG; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 535-858
100.0 1×5BB; 1×ZN; 1×MG; Crystal structure of PDE5A in complex with a novel inhibitor monomer 536-859
100.0 1×ZN; 1×MG; 1×VZF; Crystal structure of Human Phosphodiesterase 5 complexed with Sildenafil(Viagra) monomer 537-860
100.0 1×ZN; 1×MG; 1×VIA; Crystal structure of PDE5A complexed with its inhibitor monomer 535-858
100.0 1×PEG; 1×ZN; 1×MG; 1×NI5; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 537-860
100.0 1×ZN; 1×MG; 1×5IO; Crystal structure of Human Phosphodiesterase 5 complexed with Vardenafil(Levitra) monomer 537-860
100.0 1×ZN; 1×MG; 1×VDN; Crystal structure of chimeric PDE5/PDE6 catalytic domain complexed with sildenafil monomer 536-859
100 1×ZN; 1×MG; 1×VIA; Investigation of Aminopyridiopyrazinones as PDE5 Inhibitors: Evaluation of Modifications to the Cen… monomer 536-858
100 1×PD4; 1×ZN; 2×MG; A novel series of potent and selective PDE5 inhibitor2 monomer 536-858
95.52 1×ZN; 1×MG; 1×0H3; Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors monomer 538-860
100.0 1×5BO; A novel series of potent and selective PDE5 inhibitor1 monomer 536-858
94.43 1×ZN; 1×MG; 1×TGE; Crystal structure of PDE5A in complex with inhibitor L1 monomer 537-859
100.0 1×ZN; 1×MG; 1×SO4; 1×2OI; Rational Design of Highly Selective PDE5 inhibitors for the Treatment of Idiopathic Pulmonary Fibro… monomer 537-859
100.0 1×WD3; 1×ZN; 1×MG; Rational Design of Highly Selective PDE5 inhibitors for the Treatment of Idiopathic Pulmonary Fibro… monomer 537-859
100.0 1×WDB; 1×ZN; 1×MG; Crystal structure of PDE5A in complex with inhibitor L12 monomer 537-859
100.0 1×ZN; 1×MG; 1×2VI; Crystal structure of the catalytic domain of human PDE5A complexed with 2-(3-chlorobenzyl)-4-oxo-3,… monomer 537-859
100.0 1×A1D5K; 1×ZN; 1×MG; PDE5A for NaV1.7 monomer 537-858
94.41 2×ZN; 1×6LK; Crystal structure of N2 substituted pyrazolo pyrimidinones - a flipped binding mode in PDE5 monomer 537-858
100 1×ZN; 1×MG; 1×3P4; 1×MES; Identification, Synthesis, and SAR of Amino Substituted Pyrido[3,2b]pryaziones as Potent and Select… monomer 537-858
100 1×PD6; 1×ZN; 1×MG; Crystal structure of PDE5A in complex with its inhibitor monomer 537-858
100.0 1×NI0; 1×MG; 1×PEG; 1×ZN;